Basit öğe kaydını göster

dc.contributor.authorOncu, S
dc.contributor.authorEraksoy, H
dc.contributor.authorPunar, M
dc.date.accessioned2021-03-05T12:47:32Z
dc.date.available2021-03-05T12:47:32Z
dc.date.issued2004
dc.identifier.citationOncu S., Punar M., Eraksoy H., "Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates", CHEMOTHERAPY, cilt.50, ss.98-100, 2004
dc.identifier.issn0009-3157
dc.identifier.otherav_aeed76df-0004-4834-ba8e-af4665c6f2e3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/116690
dc.identifier.urihttps://doi.org/10.1159/000077810
dc.description.abstractBackground: Streptococcus pneumoniae is a leading pathogen causing pneumonia, meningitis, otitis media, bacteremia and sinusitis resulting in significant morbidity and mortality. We examined in vitro activities of five quinolones in comparison with other antibiotics against 85 invasive pneumococcal isolates. Methods: Minimal inhibitory concentrations (MICs) of penicillin G, cefuroxime, azithromycin, clarithromycin, trimethoprim-sulfamethoxazole (SXT), ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin and gemifloxacin were determined using a broth microdilution method. Results: The overall rates of resistance to penicillin (46%), cefuroxime (20%), azithromycin ( 20%), clarithromycin (18%) and SXT ( 46%) were considerable. Among all of the isolates, 9 isolates (11%) were highly resistant (MIC greater than or equal to2 mg/l) and 30 isolates (35%) had intermediate resistance (MIC 0.12-1.0 mg/l). Of the quinolones gemifloxacin and trovafloxacin had the highest activity. The penicillin resistance status of the isolates did not have any effect on the resistance pattern of new quinolones. Conclusion: The new quinolones show great potential in the treatment of invasive infections caused by both penicillin-susceptible and penicillin-resistant pneumococci. Copyright (C) 2004 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleComparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates
dc.typeMakale
dc.relation.journalCHEMOTHERAPY
dc.contributor.department, ,
dc.identifier.volume50
dc.identifier.issue2
dc.identifier.startpage98
dc.identifier.endpage100
dc.contributor.firstauthorID170424


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster